US Archives - Page 209 of 221 - European Medical Journal

Wearable Devices for Vital Sign Monitoring in Haematology and Oncology

Traditional vital sign monitoring in acute hospital settings relies on sporadic checks, posing significant challenges for hematological…

AMJ Oncology 1.1 2024

We’re excited to introduce the inaugural issue of AMJ Oncology! This publication features a comprehensive review of the 2024 ASCO Annual…

ASCO 2024: Highlights in Breast Cancer Research

The theme of this year’s American Society of Clinical Oncology (ASCO) Annual Meeting was ‘The Art and Science of Cancer Care: From Comfort…

Early Palliative Care Among Patients Recently Diagnosed with Advanced Cancers

Early integration of palliative care (PC) is recommended for advanced cancers given its clinical benefits for quality of life and survival…

Laterality Bias in Mammogram Screening

Quality is important in breast imaging, and there exist a number of excellent screening mammography quality metrics to audit readers…

Navigating Bias When Using AI in Oncology

OPTIMISING patient care and survival with AI is a rapidly advancing field of medical research. During the 2024 American Society of…

New Drugs in Oncology

The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showcased groundbreaking advancements in oncology, with…

ASCO 2024 Interview: Michael A. Postow

Immunotherapy with drugs like nivolumab and ipilimumab has been decades in the making, even long before our group at MSK was involved. The…

Dr Erika Hamilton

Director of Breast Cancer Research Program; Chair, Executive Breast Committee; Sarah Cannon Research Institute, Nashville, Tennessee, USA…

EMJ

Dr Caroline Michie

Consultant Medical Oncologist, Edinburgh Cancer Centre; Honorary Clinical Senior Lecturer, University of Edinburgh, Scotland, UK…